lactobacillus gasseri

Cell therapyexperimental

Lactobacillus gasseri is a species in the genus Lactobacillus identified in 1980 by François Gasser and his associates. — Wikipedia

Clinical trial activity

19 trials · 29 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
6
Phase 3
3
Phase 4
1

Earliest trial started May 1, 2000 (NCT00895453)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • lactobacillus gasseri
  • lactobacillus gasseri dsm 27123
  • lactobacillus gasseri ks-13

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06148714N/ADec 1, 2023Citruslabs, Maneuver Marketing
NCT05133076Phase 2Nov 30, 2021Biofortis, BioGaia AB
NCT04911751Phase 2Sep 30, 2021KoBioLabs
NCT04898348Phase 2Aug 31, 2021KoBioLabs
NCT04886778N/AJun 1, 2021Southern Medical University, Zhujiang Hospital
NCT04717726Phase 3Feb 24, 2021University of Kentucky
NCT04373512Phase 3May 31, 2020Georgetown University
NCT04246151Early Phase 1 (Phase 1)Mar 31, 2020Hamilton Health Sciences Corporation
NCT04260997N/AMar 9, 2020UAS Labs LLC
NCT04118049N/AOct 30, 2019University of Connecticut, University of Maryland
NCT04056130Phase 1Sep 16, 2019KoBioLabs, Novotech, Nucleus Network Ltd
NCT03904407N/AJun 1, 2019Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, University of North Carolina at Chapel Hill
NCT03843112Phase 4Feb 28, 2019ARTPred, Bifodan A/S, University of Copenhagen
NCT03056846N/AAug 1, 2017University of Florida, Wakunaga Pharmaceutical Co., Ltd.
NCT02592200N/AOct 1, 2015BioGaia AB, Uppsala University
NCT02744638N/AFeb 1, 2015Dairyfem R&D GmbH, University of Kiel, University of Natural Resources and Life Sciences
NCT02349711N/AJan 1, 2015University of Florida, Wakunaga Pharmaceutical Co., Ltd.
NCT00506181Phase 3Jul 1, 2007Hebrew University
NCT00895453N/AMay 1, 2000Medical University of Vienna, University of Vienna
Showing 19 of 19 trials
Page 1 / 1

Organizations

Research & Development (29)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
KoBioLabsFor profit3322019
BioGaia ABFor profit2222015
University of FloridaAcademic/Hospital2212015
Wakunaga Pharmaceutical Co., Ltd.For profit2012015
ARTPredAcademic/Hospital1012019
Bifodan A/SFor profit1012019
BiofortisFor profit1012021
CitruslabsFor profit1012023
Dairyfem R&D GmbHFor profit1012015
Georgetown UniversityAcademic/Hospital1112020
Hamilton Health Sciences CorporationAcademic/Hospital1112020
Hebrew UniversityAcademic/Hospital1112007
Maneuver MarketingFor profit1112023
Medical University of ViennaAcademic/Hospital1012000
NovotechFor profit1012019
Nucleus Network LtdFor profit1012019
Society of Urodynamics, Female Pelvic Medicine and Urogenital ReconstructionAcademic/Hospital1012019
Southern Medical UniversityAcademic/Hospital1012021
UAS Labs LLCFor profit1112020
University of ConnecticutAcademic/Hospital1112019
29 organizations
Page 1 / 2